The trademark application CLINICALLY PROVEN MILDNESS was filed by Johnson & Johnson, a U.S. corporation (the "Applicant"). Application withdrawn.
The application was filed in Dutch (English was selected as the second language).
The Refusal with reference B 018231746 was Rejected according to Article 7(1)(b) EUTMR with decision issued on December 6, 2020 by the EUIPO.